Emulate nabs $82M to scale its organ-on-a-chip business

By The Science Advisory Board staff writers

September 7, 2021 -- Emulate has secured $82 million in a series E financing round led by existing investor Northpond Ventures.

Perceptive Advisors also participated in the funding round. Emulate will use the funds to expand R&D and scale its commercial organization to support a global customer base for its organ-on-a-chip technology, according to the company. Emulate has raised a total of $225 million.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.